
    
      Part I Primary Objective To determine an optimal dose of AeroFact administered by nasal
      continuous positive airway pressure (nCPAP) versus stand of care in reducing the rate of
      intubation/cannulation and bolus surfactant instillation in the first 7 days after birth.

      Part II Primary Objective To evaluate pulmonary outcomes and respiratory utilization at 3, 6,
      9, and 12 months post-menstrual age (PMA)
    
  